Preparation of both 125 I-labeled insulin and insulin-like growth factor 1 (IGF-1) was critical because it enabled a detailed characterization of binding properties of these important hormones towards their cognate transmembrane receptors. Binding modes of hundreds of hormone derivatives were analyzed using competition radioligand binding assays. This effort has resulted in development of six insulin analogs that are today clinically used for the treatment of diabetes. Here, we will briefly summarize a history of insulin research employing iodinated hormones.

Institute of Organic Chemistry and Biochemistry The Czech Academy of Sciences Prague Czech Republic

See more in PubMed

Paton WD, Rang HP. The uptake of atropine and related drugs by intestinal smooth muscle of the guinea-pig in relation to acetylcholine receptors. Proc R Soc Lond B Biol Sci. 1965;163:1-44.

Berson SA, Yalow RS, Bauman A, Rothschild MA, Newerly K. Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects. J Clin Invest. 1956;35(2):170-190.

Berson SA, Yalow RS. General principles of radioimmunoassay. Clin Chim Acta. 1968;22(1):51-69.

Hamlin JL, Arquilla ER. Monoiodoinsulin-preparation, purification, and characterization of a biologically-active derivative substituted predominantly on tyrosine A14. J Biol Chem. 1974;249(1):21-42.

Frank BH, Peavy DE, Hooker CS, Duckworth WC. Receptor-binding properties of monoiodotyrosyl insulin isomers purified by high-performance liquid-chromatography. Diabetes. 1983;32(8):705-711.

Menting JG, Yang YW, Chan SJ, et al. Protective hinge in insulin opens to enable its receptor engagement. Proc Natl Acad Sci U S A. 2014;111(33):E3395-E3404.

Gavin JR III, Gorden P, Roth J, et al. Characteristics of the human lymphocyte insulin receptor. J Biol Chem. 1973;248(6):2202-2207.

De Meyts P. Insulin and growth hormone receptors in human cultured lymphocytes and peripheral blood monocytes. Methods Recept Res. 1976;1:301-383.

Vikova J, Collinsova M, Kletvikova E, et al. Rational steering of insulin binding specificity by intra-chain chemical crosslinking. Sci Rep. 2016;6:19431. https://doi.org/10.1038/srep19431

Ward CW, Menting JG, Lawrence MC. The insulin receptor changes conformation in unforeseen ways on ligand binding: sharpening the picture of insulin receptor activation. Bioessays. 2013;35(11):945-954.

De Meyts P. Insulin and its receptor: structure, function and evolution. Bioessays. 2004;26(12):1351-1362.

Mayer JP, Zhang F, DiMarchi RD. Insulin structure and function. Bipolymers. 2007;88(5):687-713.

Zaykov AN, Mayer JP, DiMarchi RD. Pursuit of a perfect insulin. Nat Rev Drug Discov. 2016;15(6):425-439.

Jiracek J, Zakova L. Structural perspectives of insulin receptor isoform-selective insulin analogs. Front Endocrinol. 2017;8:167. https://doi.org/10.3389/fendo.2017.00167

Zakova L, Kazdova L, Hanclova I, et al. Insulin analogues with modifications at position B26. Divergence of binding affinity and biological activity. Biochemistry. 2008;47(21):5858-5868.

Jiracek J, Zakova L, Antolíková E, et al. Implications for the active form of human insulin based on the structural convergence of highly active hormone analogues. Proc Natl Acad Sci U S A. 2010;107(5):1966-1970.

Zakova L, Kletvikova E, Veverka V, et al. Structural integrity of the B24 site in human insulin is important for hormone functionality. J Biol Chem. 2013;288(15):10230-10240.

Kosinova L, Veverka V, Novotna P, et al. Insight into the structural and biological relevance of the T/R transition of the N-terminus of the B-chain in human insulin. Biochemistry. 2014;53(21):3392-3402.

Zakova L, Kletvikova E, Lepsik M, et al. Human insulin analogues modified at the B26 site reveal a hormone conformation that is undetected in the receptor complex. Acta Crystallog D. 2014;70(10):2765-2774.

Menting JG, Whittaker J, Margetts MB, et al. How insulin engages its primary binding site on the insulin receptor. Nature. 2013;493(7431):241-245.

Scapin G, Dandey VP, Zhang Z, et al. Structure of the insulin receptor-insulin complex by single-particle cryo-EM analysis. Nature. 2018;556(7699):122-125.

Gutmann T, Schaeffer IB, Poojari C, et al. Cryo-EM structure of the complete and ligand-saturated insulin receptor ectodomain. J Cell Biol. 2020;219:e201907210. https://doi.org/10.1083/jcb.201907210

Uchikawa E, Choi E, Shang GJ, et al. Activation mechanism of the insulin receptor revealed by cryo-EM structure of the fully liganded receptor-ligand complex. Elife. 2019;8:e48630. https://doi.org/10.7554/eLife.48630.001

De Meyts P, van Obberghen E, Roth J. Mapping of the residues responsible for the negative cooperativity of the receptor-binding region of insulin. Nature. 1978;273(5663):504-509.

Kiselyov VV, Versteyhe S, Gauguin L, De Meyts P. Harmonic oscillator model of the insulin and IGF1 receptors' allosteric binding and activation. Mol Syst Biol. 2009;5:243. https://doi.org/10.1038/msb.2008.78

Drejer K, Kruse V, Larsen UD, et al. Receptor-binding and tyrosine kinase activation by insulin analogs with extreme affinities studied in human hepatoma Hepg2 cells. Diabetes. 1991;40(11):1488-1495.

Drejer K. The bioactivity of insulin analogues from in vitro receptor binding to in vivo glucose uptake. Diabetes Metab Rev. 1992;8(3):259-285.

Kurtzhals P, Schaffer L, Sorensen A, et al. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes. 2000;49(6):999-1005.

Chrudinova M, Zakova L, Marek A, et al. A versatile insulin analog with high potency for both insulin and insulin-like growth factor 1 receptors: structural implications for receptor binding. J Biol Chem. 2018;293(43):16818-16829.

LeRoith D, Kavsan VM, Koval AP, et al. Phylogeny of the insulin-like growth-factors (IGFs) and receptors-a molecular approach. Mol Reprod Dev. 1993;35(4):332-338.

LeRoith D. The insulin-like growth factor system. Exp Diabesity Res. 2003;4(4):205-212.

Clemmons DR. Role of IGF-binding proteins in regulating IGF responses to changes in metabolism. J Mol Endocrinol. 2018;61(1):T139-T169.

Denley A, Cosgrove LJ, Booker GW, Wallace JC, Forbes BE. Molecular interactions of the IGF system. Cytokine Growth Factor Rev. 2005;16(4-5):421-439.

Hexnerova R, Krizkova K, Fabry M, et al. Probing receptor specificity by sampling the conformational space of the insulin-like growth factor II C-domain. J Biol Chem. 2016;291(40):21234-21245.

Krizkova K, Chrudinova M, Povalova A, et al. Insulin-insulin-like growth factors hybrids as molecular probes of hormone: receptor binding specificity. Biochemistry. 2016;55(21):2903-2913.

Machackova K, Collinsova M, Chrudinova M, et al. Insulin-like growth factor 1 analogs clicked in the C domain: chemical synthesis and biological activities. J Med Chem. 2017;60(24):10105-10117.

Machackova K, Chrudinova M, Radosavljevic J, et al. Converting insulin-like growth factors 1 and 2 into high-affinity ligands for insulin receptor isoform A by the introduction of an evolutionarily divergent mutation. Biochemistry. 2018;57(16):2373-2382.

Machackova K, Mlcochova K, Potalitsyn P, et al. Mutations at hypothetical binding site 2 in insulin and insulin-like growth factors 1 and 2 result in receptor- and hormone-specific responses. J Biol Chem. 2019;294(46):17371-17382.

Pandini G, Frasca F, Mineo R, Sciacca L, Vigneri R, Belfiore A. Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved. J Biol Chem. 2002;277(42):39684-39695.

Belfiore A, Malaguarnera R, Vella V, et al. Insulin receptor isoforms in physiology and disease: an updated view. Endocr Rev. 2017;38(5):379-431.

Slaaby R. Specific insulin/IGF1 hybrid receptor activation assay reveals IGF1 as a more potent ligand than insulin. Sci Rep. 2015;5:7911. https://doi.org/10.1038/srep07911

Yu XW, Pandey K, Katzman AC, Alberini CM. A role for CIM6P/IGF2 receptor in memory consolidation and enhancement. eLife. 2020;9:e54781. https://doi.org/10.7554/eLife.54781

Potalitsyn P, Selicharova I, Srsen K, et al. A radioligand binding assay for the insulin-like growth factor 2 receptor. PLoS ONE. 2020;15:e0238393. https://doi.org/10.1371/journal.pone.0238393

Late-stage labeling of diverse peptides and proteins with iodine-125